Article
CMS Finalizes Mandatory GLOBE Model Implementing Most Favored Nation Drug Pricing In Medicare Part B
The Centers for Medicare & Medicaid Services has finalized a mandatory drug pricing model that ties Medicare Part B rebates to international pricing benchmarks across 19 reference countries. Beginning January 2027, manufacturers of eligible high-cost drugs will owe incremental rebates when international benchmark-based calculations exceed standard inflation rebates, with participation exemptions only for those in the voluntary GENEROUS Model.
Hogan Lovells Cadwalader
